Zentalis Pharmaceuticals, Inc. (ZNTL) Reports In-Line Q1 EPS

Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) reported Q1 EPS of ($0.50), in-line with the analyst estimate of ($0.50).

For earnings history and earnings-related data on Zentalis Pharmaceuticals, Inc. (ZNTL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat